{"altmetric_id":4692017,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Aragon Pharmaceuticals, Inc."],"first_seen_on":"2015-10-28T14:34:56+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1482229724,"links":["http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02123758?term=02123758&rank=1","https:\/\/clinicaltrials.gov\/show\/NCT02123758"],"nct_id":"NCT02123758","pubdate":"2014-04-21T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.5,"score_history":{"1y":0.25,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":7912542,"mean":6.6949158185663,"rank":6000127,"this_scored_higher_than_pct":13,"this_scored_higher_than":1062075,"rank_type":"exact","sample_size":7912542,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":241891,"mean":9.6421969076852,"rank":167152,"this_scored_higher_than_pct":16,"this_scored_higher_than":40818,"rank_type":"exact","sample_size":241891,"percentile":16},"this_journal":{"total_number_of_other_articles":21709,"mean":10.371159572508,"rank":14930,"this_scored_higher_than_pct":14,"this_scored_higher_than":3060,"rank_type":"exact","sample_size":21709,"percentile":14},"similar_age_this_journal_3m":{"total_number_of_other_articles":1049,"mean":14.51390648855,"rank":715,"this_scored_higher_than_pct":14,"this_scored_higher_than":147,"rank_type":"exact","sample_size":1049,"percentile":14}}},"demographics":[],"counts":{"total":{"posts_count":2},"facebook":{"unique_users_count":2,"unique_users":["201011209954034","43136639944"],"posts_count":2}},"posts":{"facebook":[{"title":"A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic...","url":"https:\/\/www.facebook.com\/201011209954034\/posts\/728440957211054","license":"public","citation_ids":[4692017],"posted_on":"2014-09-16T13:20:07+00:00","summary":"New clinical trial announced by Cedars-Sinai for advanced stage patients with prostate cancer.\n\nhttp:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02123758?term=02123758&rank=1","author":{"name":"The Prostate Net","url":"https:\/\/www.facebook.com\/201011209954034","facebook_wall_name":"The Prostate Net","image":"https:\/\/graph.facebook.com\/201011209954034\/picture","id_on_source":"201011209954034"}},{"title":"A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer - Full Text View - ClinicalTrials.gov","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10151072195729945&id=43136639944","license":"public","citation_ids":[4692017],"posted_on":"2016-12-20T10:28:44+00:00","summary":"Clinical trial NCT02123758 for Prostate Cancer has completed enrollment!\n\nThis clinical trial is sponsored by Aragon Pharmaceuticals, Inc.\n\nThe Official Title for this clinical trial is: A Drug-Drug Interaction, Safety and Efficacy Study With JNJ-56021927","author":{"name":"Cantria Prostate Cancer","url":"https:\/\/www.facebook.com\/43136639944","facebook_wall_name":"Cantria Prostate Cancer","image":"https:\/\/graph.facebook.com\/43136639944\/picture","id_on_source":"43136639944"}}]}}